Contrary to results obtained previously in cattle the BHK cell lysate challenge caused no reactions. On the other hand BS provoked severe reactions in 4 of the 6 pigs ( Table 1 ). The signs, which developed within a few minutes of injection, were loud fast breathing, dark red blotches on the skin where the ears had been held, staggering, collapse, loss of consciousness and apnoea. The last-mentioned persisted for about a minute, after which respiration was resumed, consciousness returned and recovery ensued. The severity of the reactions, graded subjectively as mild to very severe, is shown in Fig. 1 together with the serological results. None of the unvaccinated control pigs showed any clinical response after the i.v. BS injections other than a transient increase in respiratory rate.
To establish the allergic nature of the reactions the serum samples were examined for reaginic antibodies. The blood samples, taken weekly (days 0-63) and again at day 66 (immediately before challenge) were separated and the sera stored at -20 °C until used for passive cutaneous anaphylaxis (PCA) tests. The method used was similar to that described for cattle sera . Briefly, six 8-week-old pigs were anaesthetized with azaperone (Suicalm) and metomidate (Hypnodil, Jenssen Laboratories, Belgium) and, after clipping, the skin over the chest wall and flanks was marked out into 50 blocks, approximately 3 x 3 cm. The test sera, coded and randomized to avoid bias, were then injected intradermally (i.d.), 0-1 ml to a block, all 66 sera being used in each of the six animals. After 72 h 8 ml of 2 % Evans blue in 0-15 M saline were given i.v. followed at 30 min intervals by various sequences of the substances to be tested (BHK cell lysate, BS and bovine plasma albumin (BPA)) as shown in Table 2 . The positive reactions (purple stains at the antiserum injection sites) were measured 25 min after each i.v. injection and the mean diameters of the corresponding reactions on different pigs were calculated. The results of the PCA tests confirmed those previously obtained from the challenge tests. No antibodies against BHK cell lysate were demonstrated but reagins against BS were present in the sera of all six vaccinated pigs. The squared radii of the anti-BS reactions are shown in Fig. 1 and the results obtained using both human and cattle sera suggest that these are a linear function of the reaginic antibody titres (Stanworth, 1973; Black, 1977) . Peak titres of anti-BS reagins were found in sera taken at 7 days after vaccination, indicating that serum samples for testing purposes are best taken at about that interval after any observed reactions. It is worth noting, however, that bleedings were not carried out between the 7th and 14th days after vaccination and hence sera taken about 10 days after reactions may contain higher antibody titres, as they do in cattle (0-5% protein) (iii) 2 ml 0-5% BPA* (iv) 2 ml BS* 480 L. BLACK AND M. J. FRANCIS (Black, 1977) . The rate of decline in the level of reagins in the pig appeared to be similar to that in cattle in which a serum half-life of approximately 3 days has been calculated (Black, 1977) . The relatively short half-life of these antibodies in the serum indicates that delayed sampling may give inconclusive results because the serum antibodies were often either waning or had subsided to undemonstrable levels by 21 days after vaccination.
The severity of the clinical reactions after challenge did not correlate with the titres of reaginic antibodies in the sera (see Fig. 1 ). This agrees with the results obtained in other species and has been discussed elsewhere (Stanworth, 1973; Black, 1977) . Nevertheless, PCA reactions to BPA were observed only in sera which contained high titres of anti BS reagins.
In conclusion, the results suggest that BS, but not BHK cell remnants, in OE vaccines are potentially allergenic in pigs. Furthermore, BPA is probably one of the potentially allergenic components although other serum proteins may also be implicated. Finally, while no problem of allergy has yet been reported using commercial O/E vaccines in pigs, the results reported here may enable manufacturers to eliminate potential allergens from their vaccines.
